Prescription Opioid Addiction

When Prescription Opioid Use Becomes a Concern

You may be worried about needing a pain medicine, taking more than planned, or helping someone whose use has changed. Physical dependence can develop during prescribed opioid use and does not, by itself, mean addiction. A clinician can assess loss of control and harm while also addressing pain and withdrawal.^[1][6][7]

Prescription opioids are medicines that reduce pain by acting on opioid receptors. If opioid use disorder is present, effective treatment is available. Asking for help can start with a conversation about pain, safety, and what you want to change; it does not require choosing a rehab program first.^[1][7][17]

When Does an Opioid Overdose Need Emergency Help?

Slowed or stopped breathing after opioid use is an emergency. Give naloxone if available, call 911 immediately, and stay with the person until help arrives. Follow the product instructions for additional doses if needed; opioid overdose can require more than one dose.^[4][5]

If there is no immediate emergency but opioid use is hard to control, an assessment can help distinguish physical dependence from opioid use disorder. Effective treatments include medication and behavioral care. You can learn about treatment options without first deciding which treatment you need.^[6][1]

How Do Prescription Opioids Work?

Opioids act at opioid receptors, sites where these drugs attach and exert their effects. They can relieve pain, produce relaxation or euphoria, meaning a feeling of being “high,” and slow breathing. Methadone is a “full agonist,” meaning it fully activates opioid receptors. Buprenorphine is a “partial agonist,” which activates them less strongly.^[8][1]

Naltrexone is different. It is an opioid antagonist, meaning it blocks opioid receptors rather than activating them. Its role is treating opioid use disorder, not relieving pain with an opioid effect.^[1]

Which Medicines Are Prescription Opioids?

Oxycodone, hydrocodone, morphine, codeine, hydromorphone, oxymorphone, tramadol, prescription fentanyl, buprenorphine, and methadone can all appear in prescription pain-reliever categories. Some have additional medical roles. Buprenorphine and methadone, for example, are also used to treat opioid use disorder.^[2][1]

Fentanyl is a real pharmaceutical opioid, not a synonym for a fake drug. Prescription fentanyl is used medically in particular formulations. Illicitly manufactured fentanyl is produced and distributed outside regulated pharmaceutical channels and may appear in heroin or pills made to resemble prescription medicines. Fentanyl is estimated to be 50 to 100 times as strong as morphine.^[2]

Heroin is chemically similar to prescription opioids and can produce similar effects, but it is not used as a medicine in the United States.^[1]

Immediate-Release and Extended-Release Opioids

Immediate-release opioids release medicine over a shorter period, while extended-release formulations release it over a longer period. The broader extended-release or long-acting category includes methadone, fentanyl skin patches, and extended-release forms of oxycodone, hydromorphone, hydrocodone, and morphine. Fentanyl patches deliver medicine through the skin, a route called transdermal delivery.^[7][9]

A Centers for Disease Control and Prevention (CDC) evidence review found generally consistent short-term effects on pain and function across shorter- and longer-acting opioids. One study rated fair quality (a finding to weigh with caution rather than treat as definitive) found greater overdose risk with extended-release or long-acting opioids than with immediate-release opioids, especially during the first two weeks of treatment.^[7]

How Well Do Prescription Opioids Treat Pain?

Pain care should consider more than a pain rating. Improvement in daily activities and quality of life, treatment risks, and the person’s priorities also matter when choosing and reviewing treatment.^[7]

Opioids can reduce some kinds of pain, but their likely benefit and acceptable risk depend heavily on the clinical situation. Evidence for a short episode after an injury or procedure should not be treated as evidence for years of therapy.

Cancer pain also follows a different evidence base and care pathway from most chronic noncancer pain.

Acute, Subacute, and Chronic Pain

The 2022 CDC guideline defines acute pain as lasting less than one month, subacute pain as lasting one to three months, and chronic pain as lasting longer than three months. Its recommendations apply to adult outpatients but exclude cancer-related pain treatment, sickle cell disease, palliative care (care focused on relief of suffering) and end-of-life care. These contexts require separate guidance.^[7]

For acute pain, the relevant question is whether an opioid offers enough additional short-term relief or function to justify its risks. The CDC evidence review describes short-term effects on pain and function but does not establish that one opioid type or duration of action is consistently superior.^[7]

For chronic pain, relief at one early visit does not by itself show that treatment remains worthwhile. Follow-up should consider sustained improvement in pain, function, and quality of life, along with side effects, warning signs, and whether benefits still outweigh risks. The CDC gives a 30% improvement in both pain and function scores as one definition of clinically meaningful improvement, not as an automatic rule for every person.^[7]

The CDC guideline is intended to support individualized decisions, not inflexible limits imposed across populations. It recommends appropriate pain treatment after considering the benefits and risks of all options in the person’s circumstances.^[7]

How Nonopioid Options Fit Into Pain Care

A pain plan can include nonopioid medicines and nonmedication approaches, alone or alongside an opioid. The choice should be based on the pain condition, medical risks, previous responses, practical access, and the outcomes that matter to the person.

An opioid decision should therefore compare realistic options rather than asking whether opioids are simply “good” or “bad.” A useful goal might be walking to the mailbox, sleeping more consistently, caring for oneself, or returning to a valued activity. The CDC encourages person-centered functional goals as well as pain ratings.^[7]

Cancer-Related Pain

Cancer-related pain, palliative care, and end-of-life care have distinct treatment needs. Recommendations for other forms of chronic pain should not be applied automatically; discuss pain relief, side effects, and any concern about opioid use with the treating team.^[7][10]

How Do Opioid Use, Misuse, Dependence, and Addiction Differ?

Taking an opioid for a legitimate medical reason does not by itself mean a person has an addiction. Several related terms describe different experiences, and using them accurately avoids assuming opioid use disorder from treatment alone.^[6]

The national survey classifies use without one’s own prescription and overuse of a prescribed medicine as misuse even when the purpose is pain relief. In 2024, 70.1% of people aged 12 or older who had misused prescription pain relievers in the past year said their main reason for their last misuse was relieving physical pain.^[2]

Tolerance and physical dependence can occur during medically supervised therapy. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) does not count tolerance or withdrawal toward an opioid use disorder diagnosis when opioids are taken solely under appropriate medical supervision.^[6]

How Opioid Use Disorder Is Assessed

Opioid use disorder is diagnosed when at least two of 11 defined problems occur within one year. Two or three criteria indicate mild disorder. Four or five indicate moderate disorder. Six or more indicate severe disorder.^[6]

Assessment may explore patterns such as:

• Taking opioids in larger amounts or for longer than intended.
• Wanting to cut down but repeatedly being unable to do so.
• Spending substantial time obtaining, using, or recovering from opioids.
• Experiencing cravings.
• Having opioid-related problems at work, school, home, or in relationships.
• Giving up important activities.
• Using opioids in physically hazardous situations.
• Continuing despite known physical or psychological harm.^[6]

A clinician may begin with the person’s concerns, observed behavior, prescription drug monitoring information (records about prescribed medicines) or toxicology results, meaning tests for drugs or related substances in the body. These are reasons for a respectful conversation and structured assessment, not proof of a diagnosis by themselves.^[6]

Treatment with opioids for pain is associated with greater risk of opioid use disorder, particularly when prescribing continues beyond 90 days. Follow-up should include questions about difficulty controlling use, cravings, and opioid-related work, social, or family problems.^[6][7]

How Common Are Prescription Opioid Use, Misuse, and Addiction?

Prescription opioid use and misuse answer different questions. Use includes taking a prescription opioid whether or not it was misused; misuse describes use without one’s own prescription or differently from prescribed. The survey also measures opioid use disorder using diagnostic criteria, rather than treating all use or misuse as a disorder.^[2][11]

In 2025, an estimated 60.619 million people aged 12 or older (20.9% of that population) reported using a prescription opioid in the past year.^[12] This “any use” measure includes use with and without misuse; it is not a count of people using opioids only as directed.^[12]

The 2024 survey does provide a use-related perspective: among all past-year users of each product aged 12 or older, 9.8% of hydrocodone users and 9.7% of oxycodone users reported misusing that product.^[2] In each group, roughly nine in ten users did not report product-specific misuse.^[2] These percentages describe each product’s users, not the total number using prescription opioids or the proportion using every opioid only as directed.^[2]

Among people aged 12 or older in 2025, the National Survey on Drug Use and Health estimated:

• 6.881 million people, or 2.4%, misused prescription opioids during the past year.^[3]
• 1.816 million people, or 0.6%, misused prescription opioids during the past month.^[3]
• 7.311 million people, or 2.5%, misused opioids when illegally made fentanyl was included.^[3]
• 3.709 million people, or 1.3%, met survey criteria for prescription opioid use disorder during the past year.^[11]

The 2025 prescription opioid use disorder estimate included 207,000 adolescents aged 12 to 17 and 3.502 million adults aged 18 or older.^[11] The measure was based on Fifth Edition diagnostic criteria and survey eligibility rules.^[11]

The 2024 estimates were higher: 7.570 million people aged 12 or older reported past-year prescription opioid misuse, and 4.596 million met criteria for prescription opioid use disorder.^[3][11] The tables identify the 2024-to-2025 decline in prescription opioid use disorder as statistically significant, meaning it was unlikely to reflect survey sampling variation alone.^[3][11]

Survey categories matter. “Prescription opioids” exclude illegally made fentanyl, while the broader “opioids including illegally made fentanyl” category includes it. These estimates rely on self-report and survey definitions; they are not a count of pharmacy prescriptions, toxicology-confirmed use, or all illicit opioid exposure.^[3]

What Are the Side Effects and Overdose Risks of Prescription Opioids?

Prescription opioids can cause constipation, nausea, sleepiness, confusion, and slowed breathing. Breathing that becomes too slow can be life-threatening. The medicine, dose, other substances, and a person’s health all matter when evaluating risk.^[1]

Hydrocodone combination products, for example, can cause serious or life-threatening breathing problems, particularly early in treatment and after an increase. Product guidance tells patients to seek urgent help for slowed breathing, long pauses between breaths, or shortness of breath.^[5]

People with asthma, chronic obstructive pulmonary disease (a long-term lung disease), already-slowed breathing, or other lung problems should make sure the prescriber and pharmacist know about those conditions. This hydrocodone-specific warning illustrates why a complete medication and health history matters before starting or changing an opioid.^[5]

Opioid Interactions With Alcohol, Sedatives, and Other Medicines

Combining opioids with alcohol, benzodiazepines, or other medicines that slow breathing increases overdose risk. Tell the prescriber and pharmacist about every medicine and substance you use. CDC identifies taking opioids and benzodiazepines together as a reason to carry naloxone.^[1][4]

Interactions are not limited to sedatives. Hydrocodone combination products can interact with certain prescription, nonprescription, and herbal products. Keeping an updated list of medicines, vitamins, and supplements and sharing it with prescribers and pharmacists is a practical safety step.^[5]

Do not independently stop a benzodiazepine because of an opioid interaction concern. CDC guidance says benzodiazepine tapering must be gradual and individualized because abrupt withdrawal can cause severe complications. Decisions about which medicine to change and when should reflect patient priorities, clinical circumstances, and coordination among clinicians.^[7]

Pharmacy Medicines and Counterfeit Pills

Counterfeit pills are made to look like prescription products and may contain illicitly manufactured fentanyl. Pills not obtained from a pharmacy can therefore carry uncertainty about what they contain.^[2][13]

This distinction concerns the source, not whether fentanyl itself is “real.” Both prescription fentanyl and illicitly manufactured fentanyl are potent opioids. National overdose data indicate that illicitly manufactured fentanyl increasingly contributed to deaths that also involved prescription opioid drugs from 2014 through 2021.^[2][13]

In 2023, 13,026 U.S. overdose deaths involved prescription opioids, down overall from 17,029 in 2017.^[13] The broader opioid category accounted for 79,358 deaths, with synthetic opioids other than methadone (primarily illicitly manufactured fentanyl) involved in 72,776 deaths.^[13] A death can involve more than one drug, so these categories should not be added together.^[13]

What Should You Discuss Before Starting or Continuing an Opioid?

The core decision is not simply whether pain exists. It is whether a particular treatment is likely to improve meaningful outcomes enough to justify its risks in that person’s circumstances.

Before starting or continuing an opioid, a useful conversation can cover:

• The likely cause and expected duration of the pain.
• Which nonopioid and nonmedication options are realistic.
• What improvement would count as worthwhile.
• Current medicines, alcohol, and other substance use.
• Lung, liver, kidney, mental health, pregnancy, and overdose history.
• Possible side effects and what action to take.
• Secure storage, disposal, and access to naloxone.
• When benefits and harms will be reviewed.^[7][5]

At follow-up, the CDC recommends reviewing progress toward pain and functional goals, quality of life, adverse effects, warning signs, and whether benefits continue to outweigh risks. This is a shared reassessment, not a presumption that treatment must continue or stop.^[7]

Changing or Stopping an Opioid

Repeated opioid exposure can produce physical dependence. If a physically dependent person stops suddenly, opioid withdrawal symptoms may include restlessness, sweating, chills, muscle pain, insomnia, nausea, vomiting, diarrhea, anxiety, rapid breathing, or a fast heartbeat.^[5]

Do not make an unplanned medication change based only on fear, a population statistic, or someone else’s experience. Hydrocodone guidance specifically advises patients not to stop suddenly or change how they take it without speaking with the prescriber.^[5]

The CDC guideline emphasizes individualized care and says its recommendations should not be applied as inflexible standards. Decisions should account for the person’s goals, treatment response, risks, priorities, and access to alternative pain care.^[7]

Physical dependence alone does not establish opioid use disorder. If the concern is loss of control, craving, repeated harmful use, or major life disruption, ask for an opioid use disorder assessment rather than treating the issue only as a medication taper.^[6]

Which Treatments Help Opioid Use Disorder?

People with opioid use disorder who are treated with methadone or buprenorphine are less likely to die or to have an overdose than those who do not receive treatment.^[17]

Opioid use disorder is treatable. The three U.S. Food and Drug Administration-approved medications identified in CDC guidance are buprenorphine, methadone, and naltrexone. They work differently, and guidance cautions against presenting them as interchangeable choices.^[7]

The medicines differ in receptor effects and in the steps needed to begin treatment. These differences are worth discussing with a treatment provider.^[7]

Buprenorphine and methadone have stronger evidence for better outcomes than antagonist treatment, do not require prior abstinence in the same way naltrexone does, and are more widely used. Evidence specific to opioid use disorder involving prescription opioids is more limited than evidence for broader opioid use disorder, but that limitation does not mean treatment is ineffective.^[7]

Buprenorphine Maintenance Versus Tapering

A 14-week randomized trial at one primary care site enrolled 113 people with prescription opioid dependence.^[14] Randomized means participants were assigned to groups by chance. All received counseling and clinical support. The comparison was ongoing buprenorphine-naloxone treatment versus a three-week taper, or gradual reduction, after six weeks of stabilization; the taper group was then offered naltrexone.^[14]

Buprenorphine-naloxone combines two medicines. In this treatment product, naloxone is added to reduce the likelihood of misuse and diversion, meaning transfer of medicine to someone other than the intended patient. This combination treatment is distinct from naloxone given on its own to reverse an overdose.^[8][4]

In this trial, maintenance improved the proportion of opioid-negative urine samples: 53.2% of samples in the maintenance group versus 35.2% in the taper group.^[14] Participants completed the trial at rates of 66% with maintenance and 11% with tapering.^[14] Sixteen taper-group participants restarted buprenorphine after relapse.^[14]

Practically, this trial found better retention (remaining in treatment) and less opioid use with ongoing treatment than with a short taper. It was small, short, and conducted at one site under an older “prescription opioid dependence” diagnosis, so it does not determine the right treatment duration for every person. It does show why maintenance should not be dismissed as merely postponing recovery.^[14]

Buprenorphine Compared With Methadone

A 24-week Canadian trial randomly assigned 272 treatment-seeking adults with prescription-type opioid use disorder to flexible take-home buprenorphine-naloxone or closely supervised methadone. The trial was open-label, meaning participants and clinicians knew the assigned treatment.^[15]

Buprenorphine-naloxone was noninferior for reducing opioid use: it met the study’s standard, set before results were analyzed, for not being unacceptably worse on opioid-free urine tests. The noninferiority margin allowed a difference between groups of up to 15 percentage points.^[15] It did not require identical results or establish superiority.^[15]

To assess the difference between groups, the trial measured opioid-free urine samples: averages were 24.0% with buprenorphine-naloxone and 18.5% with methadone.^[15] However, the buprenorphine-naloxone group had reduced odds of remaining in the assigned treatment, about half the odds in the methadone group.^[15] This is not evidence that the medicines were equivalent on every outcome.^[15]

Because the trial was conducted in Canada using flexible take-home buprenorphine-naloxone and closely supervised methadone, its results should be applied with attention to local treatment pathways. Its practical lesson is that reducing opioid use and remaining in assigned treatment are distinct outcomes.^[15] Ask a treatment provider how each option would fit your circumstances and what support would help you continue care.

Behavioral Treatment and Recovery Support for Opioid Use Disorder

Behavioral treatment can help people manage triggers and stress, develop healthier skills, and continue with medication. Cognitive behavioral therapy works on expectations and behaviors connected with drug use, while other supports may address relationships, daily stability, and recovery goals.^[1]

A systematic review (a structured review of multiple studies) examined behavioral interventions added to opioid agonist treatment. It found that contingency management, an approach providing rewards for agreed treatment behaviors, might improve retention. Aside from retention, few differences were found consistently between behavioral approaches plus medication and medication alone.^[16]

The review mainly included men, often excluded people with coexisting mental health conditions, and contained only one study focused on chronic pain and prescription opioid use. Behavioral programs also varied substantially. These limits make it difficult to identify one best approach for every person.^[16]

More intensive counseling does not necessarily add benefit to medication treatment. In one prescription-opioid study discussed by the CDC, more intensive counseling did not demonstrate better outcomes than standard medical management when both accompanied buprenorphine. Counseling or medical management without buprenorphine did not prevent return to use. Ask what medication and support options are feasible rather than assuming intensive counseling is the only pathway.^[7]

Recovery may involve ongoing medication, counseling, peer support or recovery-coach services, and other services in different combinations over time. The Substance Abuse and Mental Health Services Administration notes that buprenorphine treatment duration is tailored to the individual and can be indefinite in some cases.^[8][2]

How Can Families Reduce Opioid Overdose Risk?

Naloxone is a medication that temporarily reverses opioid overdose. It can restore breathing within two to three minutes when breathing has slowed or stopped because of an opioid, although more than one dose may be required. Naloxone will not harm someone whose overdose was caused by a nonopioid drug.^[4]

CDC particularly encourages naloxone for people with opioid use disorder, people taking high-dose prescription opioids, people combining opioids with benzodiazepines, and people using illicit opioids. Because a person cannot administer naloxone to themselves during an overdose, others should know where it is and how to use it.^[4]

If someone may be overdosing:

1. Give naloxone if it is available.
2. Call 911 immediately.
3. Stay with the person and monitor breathing until help arrives.
4. Give another dose according to the product instructions if symptoms return before emergency help arrives.^[5]

Naloxone is available over the counter in all 50 states. Cost and local stock can vary. Ask a pharmacist or prescriber about access, or check a community naloxone program. CDC also identifies most syringe services programs (community services for people who use injection drugs) as places to obtain naloxone.^[4]

How to Store and Dispose of Opioids Safely

Store opioids in their original container, tightly closed, out of sight and reach of children, and preferably in a locked location. Do not share them. A dose tolerated by the person for whom it was prescribed can cause overdose in someone else, and children and pets are especially vulnerable to accidental ingestion.^[7][5]

The Food and Drug Administration says a drug take-back program is the best disposal option for most expired or unused medicines. Options may include authorized collection sites, pharmacy kiosks, take-back events, or prepaid mail-back envelopes.^[9]

If take-back is not readily available, check the label or Food and Drug Administration flush list. Only medicines specifically listed for flushing should be flushed. Most other medicines can go in household trash after being mixed with an undesirable material, sealed in a container, and stripped of personal information.^[9]

Used fentanyl patches require special attention because substantial medicine can remain in the patch. Food and Drug Administration instructions call for flushing used or leftover fentanyl patches when a take-back option is not readily available.^[9]

Prescription Opioid Addiction FAQs

Does Physical Dependence Mean Addiction?

No. Physical dependence means the body has adapted and may develop withdrawal if the opioid is reduced or stopped. Opioid use disorder involves a broader pattern of impaired control or harmful consequences. Tolerance and withdrawal do not count toward the diagnosis when opioids are used solely under appropriate medical supervision.^[6]

Can Someone Misuse an Opioid to Treat Real Pain?

Yes. National survey definitions count taking someone else’s prescription pain reliever or using one’s own more often or at a higher amount than directed as misuse, even when the purpose is pain relief. In 2024, among people aged 12 or older, pain relief was the main reason for the last misuse among 70.1% of past-year prescription pain-reliever misusers.^[2]

Is Prescription Fentanyl the Same as Counterfeit Fentanyl Pills?

No. Prescription fentanyl is used medically. Counterfeit pills are made to resemble prescription drugs and may contain illicitly manufactured fentanyl. Pills not obtained from a pharmacy can carry uncertainty about what they contain; fentanyl itself is a real and highly potent opioid.^[2][13]

Is Medication for Opioid Use Disorder Replacing One Addiction With Another?

No. Buprenorphine and methadone are prescribed treatments that act on opioid receptors to reduce withdrawal and cravings. Evidence supports ongoing medication treatment, and a randomized trial in prescription opioid dependence found substantially better retention and less opioid use with buprenorphine maintenance than with a short taper.^[1][14]

How Can You Get Help With Prescription Opioid Concerns?

If you are considering an opioid for pain, ask what improvement the treatment is expected to produce, what alternatives are realistic, what side effects deserve action, when progress will be reviewed, and whether naloxone would add protection.

If you already take an opioid, keep an updated medicine and supplement list, use the medicine only as directed, secure it from others, and arrange safe disposal when it is no longer needed. Do not make an abrupt change if physical dependence may be present.^[5]

If opioid use feels difficult to control, ask for a nonjudgmental opioid use disorder assessment. Discuss buprenorphine, methadone, and naltrexone rather than assuming withdrawal management alone is the only option. Treatment and rehabilitation can be ongoing, and returning to care after a setback is still part of recovery.^[6][7]

In the United States, FindTreatment.gov lists state-licensed substance use and mental health providers. The Substance Abuse and Mental Health Services Administration National Helpline is 1-800-662-HELP (4357).^[8]

For questions about a poisoning, Poison Control is available at 1-800-222-1222. For a substance use, mental health, or emotional crisis, call or text 988. Call 911 for immediate danger.^[13]